Ziclaseg 30mg prolonged-release tablets

Maa: Yhdistynyt kuningaskunta

Kieli: englanti

Lähde: myHealthbox

Aktiivinen ainesosa:

gliclazide

Saatavilla:

Lupin (Europe) Limited

ATC-koodi:

A10BB09

INN (Kansainvälinen yleisnimi):

gliclazide

Annos:

30mg

Lääkemuoto:

Prolonged-release tablet

Antoreitti:

oral use

Kpl paketissa:

10, 20, 28, 30, 56, 60, 90 and 120 tablets

Prescription tyyppi:

POM - Prescription Only Medicine

Valmistaja:

Lupin (Europe) Ltd

Terapeuttinen ryhmä:

Sulfonamides, urea derivatives

Käyttöaiheet:

Non insulin-dependent diabetes (type 2) in adults when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose.

Valtuutuksen tilan:

Authorised

Valtuutus päivämäärä:

2015-12-04

Pakkausseloste

PACKAGE LEAFLET: INFORMATION FOR THE USER
ZICLASEG 30MG PROLONGED RELEASE TABLET
GLICLAZIDE
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS 
MEDICINE.
–   Keep this leaflet. You may need to read it again
–  If  you  have  any  further  questions,  ask  your  doctor  or 
pharmacist
–  This medicine has been prescribed for you. Do not pass it on 
to others. It may harm 
  them, even if their symptoms are the same as yours.
–  If any of the side effects gets serious, or if you notice any 
side effects not listed in this leaflet, please tell your doctor 
or pharmacist.
IN THIS LEAFLET:
1.  What Ziclaseg Tablets are and what they are used for
2.  Before you take Ziclaseg Tablets
3.  How to take_ _Ziclaseg Tablets 
4.  Possible side effects
5.  How to store Ziclaseg Tablets
6.  Further information
1. WHAT ZICLASEG TABLETS ARE AND WHAT THEY ARE 
USED FOR
Ziclaseg is a medicine which 
REDUCES BLOOD SUGAR LEVELS (oral 
antidiabetic medicine belonging to the sulphonylurea group).
Ziclaseg 30mg prolonged release tablets are used to keep blood 
sugar at the correct level in adults with 
DIABETES when it is not 
controlled by dietary measures, physical exercise and weight 
loss alone.  
2. BEFORE YOU TAKE ZICLASEG TABLETS 
DO NOT TAKE ZICLASEG 30MG PROLONGED RELEASE TABLETS:
−  if you are
 ALLERGIC (hypersensitive) TO GLICLAZIDE or any 
of  the  other  ingredients  in  this  medicine  (see  section 
6,“Further Information”) or to any other medicines of the 
same group (sulphonylureas or sulphonamides).
−  if you have insulin-dependent (Type 1) 
DIABETES;
−  if you have ketone bodies and sugar in your urine (this 
may  mean  you  have 
DIABETIC  KETO-ACIDOSIS),  diabetic 
pre-coma or coma
−  if you have 
SEVERE KIDNEY OR LIVER DISEASE;
−  if  you  are  taking  any  medicine

Valmisteyhteenveto

=LFODVHJPJSURORQJHGUHOHDVHWDEOHWV
6XPPDU\RI3URGXFW&KDUDFWHULVWLFV8SGDWHG'HF_/XSLQ(XURSH/WG
1DPHRIWKHPHGLFLQDOSURGXFW
=LFODVHJPJSURORQJHGUHOHDVHWDEOHWV
4XDOLWDWLYHDQGTXDQWLWDWLYHFRPSRVLWLRQ
(DFKWDEOHWFRQWDLQVPJJOLFOD]LGH
)RUDIXOOOLVWRIH[FLSLHQWVVHHVHFWLRQ
3KDUPDFHXWLFDOIRUP
3URORQJHGUHOHDVHWDEOHW
:KLWHWRRIIZKLWHFDSVXOHVKDSHGELFRQYH[WDEOHWGHERVVHGZLWK³´RQRQHVLGHDQGSODLQRQWKHRWKHUVLGH
&OLQLFDOSDUWLFXODUV
7KHUDSHXWLFLQGLFDWLRQV
1RQLQVXOLQGHSHQGHQWGLDEHWHVW\SHLQDGXOWVZKHQGLHWDU\PHDVXUHVSK\VLFDOH[HUFLVHDQGZHLJKWORVVDORQHDUH
QRWVXIILFLHQWWRFRQWUROEORRGJOXFRVH
3RVRORJ\DQGPHWKRGRIDGPLQLVWUDWLRQ
)RURUDOXVH
$GXOWV
7KHGDLO\GRVHPD\YDU\IURPWRWDEOHWVSHUGD\LH±PJWDNHQRUDOO\LQDVLQJOHLQWDNHDWEUHDNIDVWWLPH
,WLVUHFRPPHQGHGWKDWWKHWDEOHWVDUHVZDOORZHGZKROHZLWKRXWFKHZLQJ
$VZLWKDQ\K\SRJO\FDHPLFDJHQWWKHGRVHVKRXOGEHDGMXVWHGDFFRUGLQJWRWKHLQGLYLGXDOSDWLHQWVPHWDEROLFUHVSRQVH
EORRGJOXFRVH+E$OF
,QLWLDO'RVH
7KHUHFRPPHQGHGVWDUWLQJGRVHLVPJGDLO\
,IEORRGJOXFRVHLVHIIHFWLYHO\FRQWUROOHGWKLVGRVHPD\EHXVHGIRUPDLQWHQDQFHWUHDWPHQW
,IEORRGJOXFRVHLVQRWDGHTXDWHO\FRQWUROOHGWKHGRVHPD\EHLQFUHDVHWRRUPJGDLO\LQVXFFHVVLYHVWHSV
7KHLQWHUYDOEHWZHHQHDFKGRVHLQFUHPHQWVKRXOGEHDWOHDVWPRQWKH[FHSWLQSDWLHQWVZKRVHEORRGJOXFRVHKDVQRW
UHGXFHGDIWHUWZRZHHNVRIWUHDWPHQW,QVXFKFDVHVWKHGRVHPD\EHLQFUHDVHGDWWKHHQGRIWKHVHFRQGZHHNRI
WUHDWPHQW
7KHPD[LPXPUHFRPPHQGHGGDLO\GRVHLVPJ
6ZLWFKLQJIURP*OLFOD]LGHPJWDEOHWVWR=LFODVHJPJSURORQJHGUHOHDVHWDEOHWV
WDEOHWRI*OLFOD]LGHPJLVFRPSDUDEOHWRWDEOHWRI=LFODVHJPJSURORQJHGUHOHDVHWDEOHWV&RQVHTXHQWO\WKH
VZLWFKFDQEHSHUIRUPHGSURYLGHGDFDUHIXOEORRGPRQLWRULQJ
6ZLWFKLQJIURPDQRWKHURUDODQWLGLDEHWLFDJHQWWR=LFODVHJPJSURORQJHGUHOHDVHWDEOHWV
=LFODVHJPJSURORQJHGUHOHDVHWDEOHWVFDQEHXVHGW